PLAUR and melanoma: Biagioni et al. also knocked out uPAR using the CRISPR/Cas9 system in human melanoma A375p and A375M6 cells and colon cancer HCT116 cells, inducing extensive glycolytic and oxidative phosphorylation reprogramming by blocking the glycolytic pathway while enhancing the mitochondrial spare respiratory capacity [200].